• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病血液透析患者的动脉僵硬度变化:对死亡率的影响。

The arterial stiffness changes in hemodialysis patients with chronic kidney disease: The impact on mortality.

作者信息

Rekucki Konrad, Sławuta Agnieszka, Zyśko Dorota, Madziarska Katarzyna

机构信息

Department of Cardiology, T. Marciniak Lower Silesian Specialist Hospital, Wrocław, Poland.

Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, Poland.

出版信息

Adv Clin Exp Med. 2022 Jul;31(7):757-767. doi: 10.17219/acem/146970.

DOI:10.17219/acem/146970
PMID:35394129
Abstract

BACKGROUND

Patients with kidney disease suffer from high cardiovascular risk due to classic and disease-specific risk factors. Arterial stiffness is a novel cardiovascular risk factor whose role is yet to be established. High-resolution echo-tracking is a developing method for the assessment of local arterial stiffness.

OBJECTIVES

To assess carotid stiffness in patients on long-term hemodialysis (HD) using high-resolution echo-tracking and to analyze the impact of arterial stiffness on mortality in the mid-term follow-up.

MATERIAL AND METHODS

Fifty-eight HD patients (28 female (F), 30 male (M)) underwent clinical examination, laboratory tests and carotid stiffness assessment. Local arterial stiffness parameters such as beta stiffness index (β), Young's modulus (Ep), arterial compliance (AC), and one-point pulse wave velocity (PWVβ) were measured both before and after HD, allowing to calculate their change (Δ). The survival of patients was analyzed up to 48 months. The multivariate analysis of survival with the use of Cox proportional hazard stepwise regression was performed to determine the factors significantly correlated with the survival.

RESULTS

After 48 months, 33 patients were alive (16 F, 17 M) and 25 patients (12 F, 13 M) died. The deceased group was significantly older (66.5 ±12.3 years compared to 56.6 ±17.8 years), had more pronounced coronary artery disease (percutaneous coronary intervention (PCI) 36% compared to 9%, p < 0.05, respectively). Deceased patients had significantly higher ΔAC than survivors. The results showed that age, history of PCI, left ventricular ejection fraction (LVEF), ΔAC, fasting glucose, serum total protein, sodium level after HD, and potassium level before HD were significantly associated with mortality.

CONCLUSIONS

Echo-tracking-based arterial stiffness assessment in patients with chronic kidney disease (CKD) yields the clinical information regarding mid-term mortality risk. A paradoxical increase in AC is among independent risk factors for mid-term mortality in patients undergoing maintenance HD. The proper estimation of the correlations among vascular, hemodynamic and sympathetic-dependent changes in a given patient with kidney failure is complex.

摘要

背景

由于经典和疾病特异性危险因素,肾病患者存在较高的心血管风险。动脉僵硬度是一种新型心血管危险因素,其作用尚未明确。高分辨率回声跟踪是一种用于评估局部动脉僵硬度的发展中的方法。

目的

使用高分辨率回声跟踪评估长期血液透析(HD)患者的颈动脉僵硬度,并分析中期随访中动脉僵硬度对死亡率的影响。

材料与方法

58例HD患者(28例女性(F),30例男性(M))接受了临床检查、实验室检查和颈动脉僵硬度评估。在HD前后测量局部动脉僵硬度参数,如β僵硬度指数(β)、杨氏模量(Ep)、动脉顺应性(AC)和单点脉搏波速度(PWVβ),从而计算其变化(Δ)。对患者进行长达48个月的生存分析。使用Cox比例风险逐步回归进行生存的多变量分析,以确定与生存显著相关的因素。

结果

48个月后,33例患者存活(16例F,17例M),25例患者(12例F,13例M)死亡。死亡组年龄显著更大(分别为66.5±12.3岁和56.6±17.8岁),冠状动脉疾病更明显(经皮冠状动脉介入治疗(PCI)分别为36%和9%,p<0.05)。死亡患者的ΔAC显著高于存活者。结果表明,年龄、PCI病史、左心室射血分数(LVEF)、ΔAC、空腹血糖、血清总蛋白、HD后钠水平和HD前钾水平与死亡率显著相关。

结论

基于回声跟踪的慢性肾脏病(CKD)患者动脉僵硬度评估可提供有关中期死亡风险的临床信息。AC的反常增加是维持性HD患者中期死亡的独立危险因素之一。正确估计特定肾衰竭患者血管、血流动力学和交感神经依赖性变化之间的相关性很复杂。

相似文献

1
The arterial stiffness changes in hemodialysis patients with chronic kidney disease: The impact on mortality.慢性肾脏病血液透析患者的动脉僵硬度变化:对死亡率的影响。
Adv Clin Exp Med. 2022 Jul;31(7):757-767. doi: 10.17219/acem/146970.
2
Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.在血液透析患者中,血清骨保护素是使用颈股脉搏波速度评估的中心动脉僵硬度的独立标志物:一项横断面研究。
BMC Nephrol. 2019 May 23;20(1):184. doi: 10.1186/s12882-019-1374-2.
3
Prevalence of Arterial Stiffness and Associated Factors in Thai Patients with Chronic Kidney Disease and Kidney Transplant Recipients.泰国慢性肾脏病患者及肾移植受者的动脉僵硬度患病率及相关因素
J Med Assoc Thai. 2017 Feb;100 Suppl 1:S56-69.
4
Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.血清钙磷复合物颗粒大小和转化时间与新发生血液透析患者动脉钙化、动脉僵硬度和死亡率的相关性。
Am J Kidney Dis. 2021 Mar;77(3):346-354. doi: 10.1053/j.ajkd.2020.05.031. Epub 2020 Aug 13.
5
Subclinical markers of cardiovascular disease predict adverse outcomes in chronic kidney disease patients with normal left ventricular ejection fraction.心血管疾病的亚临床标志物可预测左心室射血分数正常的慢性肾脏病患者的不良结局。
Int J Cardiovasc Imaging. 2017 May;33(5):687-698. doi: 10.1007/s10554-016-1059-x. Epub 2017 Jan 24.
6
The relationship of carotid arterial stiffness to left ventricular diastolic dysfunction in untreated hypertension.未经治疗的高血压患者颈动脉僵硬度与左心室舒张功能障碍的关系。
Kardiol Pol. 2012;70(3):223-31.
7
Atorvastatin can delay arterial stiffness progression in hemodialysis patients.阿托伐他汀可延缓血液透析患者动脉僵硬进展。
Int Urol Nephrol. 2022 Nov;54(11):2969-2976. doi: 10.1007/s11255-022-03231-3. Epub 2022 May 18.
8
Arterial Stiffness Assessed by Oscillometric Method in Kidney Transplant, Predialysis, and Dialysis Patients.通过示波法评估肾移植患者、透析前患者和透析患者的动脉僵硬度。
Transplant Proc. 2020 Oct;52(8):2337-2340. doi: 10.1016/j.transproceed.2020.01.132. Epub 2020 Apr 29.
9
Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients.血液透析患者的动态脉波速度比诊室血压和动态血压更能准确预测心血管事件和全因死亡率。
Hypertension. 2017 Jul;70(1):148-157. doi: 10.1161/HYPERTENSIONAHA.117.09023. Epub 2017 May 8.
10
Different circadian patterns of arterial stiffness are responsible for increased cardiovascular mortality in hemodialyzed patients.不同的动脉僵硬昼夜节律模式是导致血液透析患者心血管死亡率增加的原因。
Physiol Rep. 2021 Nov;9(21):e15082. doi: 10.14814/phy2.15082.

引用本文的文献

1
Energy Homeostasis Gene Nucleotide Variants and Survival of Hemodialysis Patients-A Genetic Cohort Study.能量稳态基因核苷酸变异与血液透析患者的生存——一项基因队列研究
J Clin Med. 2022 Sep 18;11(18):5477. doi: 10.3390/jcm11185477.